{
    "nctId": "NCT05673850",
    "briefTitle": "Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or Chemotherapy",
    "officialTitle": "Association Between HER2 Status and pCR Rate in ER-positive Breast Cancer Receiving Neoadjuvant Endocrine or Chemotherapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 518,
    "primaryOutcomeMeasure": "pathologic complete response rate (pCR)",
    "eligibilityCriteria": "Inclusion Criteria:\n\npatients diagnosed with invasive breast cancer and who received surgery from 2015 to 2021\n\nExclusion Criteria:\n\nnone",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}